OBJECTIVE: To determine the total burden of illness, including direct and indirect costs for employees and their dependents with acute coronary syndrome (ACS). METHODS: Medical and pharmacy claims along with short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 were analyzed using two data sets: Integrated Benefits Institute's Health and Productivity Benchmarking Database (STD and LTD claims) and IMS LifeLink™ Health Plan Data (medical and pharmacy claims). RESULTS: Employees with ACS lost 60.2 ± 0.29 STD and 397.9 ± 8.09 LTD days per disability incident. For employers, the estimated average per claim productivity loss from STD and LTD was $7943 ± 39.7 and $52,473 ± 1114, respectively. Total annual ACS health care costs per employee were $8170 ± 106, with $7545 ± 104 for annual medical costs. Hospitalizations accounted for 75% of total annual ACS health care costs. CONCLUSIONS: ACS imposes a substantial economic burden on employees, employers, and society.
OBJECTIVE: To determine the total burden of illness, including direct and indirect costs for employees and their dependents with acute coronary syndrome (ACS). METHODS: Medical and pharmacy claims along with short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 were analyzed using two data sets: Integrated Benefits Institute's Health and Productivity Benchmarking Database (STD and LTD claims) and IMS LifeLink™ Health Plan Data (medical and pharmacy claims). RESULTS: Employees with ACS lost 60.2 ± 0.29 STD and 397.9 ± 8.09 LTD days per disability incident. For employers, the estimated average per claim productivity loss from STD and LTD was $7943 ± 39.7 and $52,473 ± 1114, respectively. Total annual ACS health care costs per employee were $8170 ± 106, with $7545 ± 104 for annual medical costs. Hospitalizations accounted for 75% of total annual ACS health care costs. CONCLUSIONS: ACS imposes a substantial economic burden on employees, employers, and society.
Authors: Sylvia Brandt; Brenton Dickinson; Rakesh Ghosh; Frederick Lurmann; Laura Perez; Bryan Penfold; John Wilson; Nino Künzli; Rob McConnell Journal: Sci Total Environ Date: 2017-05-29 Impact factor: 7.963
Authors: Pedro Gabriel Melo de Barros; John Li; Christine Tremblay; Mariana Yumi Okada; Henry Sznejder; Valter Furlan; Rafael Vasconcellos Journal: Clinics (Sao Paulo) Date: 2020-08-26 Impact factor: 2.365
Authors: Pablo Juan-Salvadores; Cesar Veiga; Víctor Alfonso Jiménez Díaz; Alba Guitián González; Cristina Iglesia Carreño; Cristina Martínez Reglero; José Antonio Baz Alonso; Francisco Caamaño Isorna; Andrés Iñiguez Romo Journal: Diagnostics (Basel) Date: 2022-02-06
Authors: Robert L Page; Vahram Ghushchyan; Jill Van Den Bos; Travis J Gray; Greta L Hoetzer; Durgesh Bhandary; Kavita V Nair Journal: Vasc Health Risk Manag Date: 2016-02-03
Authors: Pablo Juan-Salvadores; Víctor Alfonso Jiménez Díaz; Ana Rodríguez González de Araujo; Cristina Iglesia Carreño; Alba Guitián González; Cesar Veiga Garcia; José Antonio Baz Alonso; Francisco Caamaño Isorna; Andrés Iñiguez Romo Journal: J Interv Cardiol Date: 2022-07-30 Impact factor: 1.776
Authors: Pablo Juan-Salvadores; Víctor Alfonso Jiménez Díaz; Cristina Iglesia Carreño; Alba Guitián González; Cesar Veiga; Cristina Martínez Reglero; José Antonio Baz Alonso; Francisco Caamaño Isorna; Andrés Iñiguez Romo Journal: J Cardiovasc Dev Dis Date: 2022-03-11